Oral Dalfampridine Improves Standing Balance Detected at Static Posturography in Multiple Sclerosis

We report a 14-week post-marketing experience on 20 patients with multiple sclerosis (MS) who started prolonged-release (PR) oral dalfampridine 10 mg twice daily according to European Medicine Agency criteria. They underwent serial static posturography assessments and the dizziness handicap inventor...

Descripción completa

Detalles Bibliográficos
Autores principales: Prosperini, Luca, Giannì, Costanza, Fortuna, Deborah, Marchetti, Maria Rita, Pozzilli, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985326/
https://www.ncbi.nlm.nih.gov/pubmed/24800078
http://dx.doi.org/10.1155/2014/802307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985326/
https://www.ncbi.nlm.nih.gov/pubmed/24800078
http://dx.doi.org/10.1155/2014/802307

Ejemplares similares